Go Pro

Genus (GNS) Competitors

Genus logo
GBX 2,282 -16.00 (-0.70%)
As of 08/21/2026 12:30 PM Eastern

GNS vs. IGG, SMWH, CPG, ALLG, and CVSG

Should you buy Genus stock or one of its competitors? Genus's main competitors and comparable companies include IG Group (IGG), WH Smith (SMWH), Compass Group (CPG), ALLG.L (ALLG), and CVS Group (CVSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "diversified consumer services" industry.

How does Genus compare to IG Group?

IG Group (LON:IGG) and Genus (LON:GNS) are both consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

IG Group pays an annual dividend of GBX 46.50 per share and has a dividend yield of 3.5%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.4%. IG Group pays out 44.2% of its earnings in the form of a dividend. Genus pays out 45.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. IG Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

IG Group has higher revenue and earnings than Genus. IG Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IG Group£949.10M4.64£533.35M£105.1012.69
Genus£672M2.26£7.87M£71.0032.14

IG Group has a beta of 0.503, indicating that its stock price is 50% less volatile than the broader market. Comparatively, Genus has a beta of 0.896, indicating that its stock price is 10% less volatile than the broader market.

IG Group presently has a consensus target price of GBX 1,338, suggesting a potential upside of 0.30%. Genus has a consensus target price of GBX 3,216.67, suggesting a potential upside of 40.96%. Given Genus' higher probable upside, analysts clearly believe Genus is more favorable than IG Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IG Group
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, IG Group had 3 more articles in the media than Genus. MarketBeat recorded 3 mentions for IG Group and 0 mentions for Genus. IG Group's average media sentiment score of 0.00 equaled Genus'average media sentiment score.

Company Overall Sentiment
IG Group Neutral
Genus Neutral

IG Group has a net margin of 30.26% compared to Genus' net margin of 7.07%. IG Group's return on equity of 19.99% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
IG Group30.26% 19.99% 10.37%
Genus 7.07%9.70%3.31%

74.0% of IG Group shares are held by institutional investors. Comparatively, 51.9% of Genus shares are held by institutional investors. 1.2% of IG Group shares are held by company insiders. Comparatively, 0.7% of Genus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

IG Group beats Genus on 13 of the 16 factors compared between the two stocks.

How does Genus compare to WH Smith?

WH Smith (LON:SMWH) and Genus (LON:GNS) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

WH Smith currently has a consensus price target of GBX 570, indicating a potential upside of 36.63%. Genus has a consensus price target of GBX 3,216.67, indicating a potential upside of 40.96%. Given Genus' stronger consensus rating and higher possible upside, analysts plainly believe Genus is more favorable than WH Smith.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WH Smith
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

WH Smith has higher revenue and earnings than Genus. WH Smith is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WH Smith£1.59B0.40£63.01M-£96.70N/A
Genus£672M2.26£7.87M£71.0032.14

In the previous week, WH Smith's average media sentiment score of 0.00 equaled Genus'average media sentiment score.

Company Overall Sentiment
WH Smith Neutral
Genus Neutral

WH Smith pays an annual dividend of GBX 17.30 per share and has a dividend yield of 4.1%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.4%. WH Smith pays out -17.9% of its earnings in the form of a dividend. Genus pays out 45.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. WH Smith is clearly the better dividend stock, given its higher yield and lower payout ratio.

WH Smith has a beta of 0.933, indicating that its stock price is 7% less volatile than the broader market. Comparatively, Genus has a beta of 0.896, indicating that its stock price is 10% less volatile than the broader market.

Genus has a net margin of 7.07% compared to WH Smith's net margin of -9.48%. Genus' return on equity of 9.70% beat WH Smith's return on equity.

Company Net Margins Return on Equity Return on Assets
WH Smith-9.48% -90.46% 6.62%
Genus 7.07%9.70%3.31%

71.9% of WH Smith shares are held by institutional investors. Comparatively, 51.9% of Genus shares are held by institutional investors. 0.9% of WH Smith shares are held by company insiders. Comparatively, 0.7% of Genus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

WH Smith beats Genus on 8 of the 15 factors compared between the two stocks.

How does Genus compare to Compass Group?

Genus (LON:GNS) and Compass Group (LON:CPG) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Genus has a net margin of 7.07% compared to Compass Group's net margin of 4.20%. Compass Group's return on equity of 26.12% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Genus7.07% 9.70% 3.31%
Compass Group 4.20%26.12%7.52%

Genus presently has a consensus price target of GBX 3,216.67, indicating a potential upside of 40.96%. Compass Group has a consensus price target of GBX 2,932.50, indicating a potential upside of 9,381.09%. Given Compass Group's higher possible upside, analysts plainly believe Compass Group is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Compass Group
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
3.00

Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.4%. Compass Group pays an annual dividend of GBX 66.38 per share and has a dividend yield of 214.6%. Genus pays out 45.1% of its earnings in the form of a dividend. Compass Group pays out 55.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Compass Group has higher revenue and earnings than Genus. Compass Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genus£672M2.26£7.87M£71.0032.14
Compass Group£48.49B0.01£1.35B£118.700.26

In the previous week, Genus' average media sentiment score of 0.00 equaled Compass Group'saverage media sentiment score.

Company Overall Sentiment
Genus Neutral
Compass Group Neutral

Genus has a beta of 0.896, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Compass Group has a beta of 0.653, suggesting that its share price is 35% less volatile than the broader market.

51.9% of Genus shares are held by institutional investors. Comparatively, 68.2% of Compass Group shares are held by institutional investors. 0.7% of Genus shares are held by insiders. Comparatively, 0.5% of Compass Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Compass Group beats Genus on 9 of the 15 factors compared between the two stocks.

How does Genus compare to ALLG.L?

Genus (LON:GNS) and ALLG.L (LON:ALLG) are both consumer discretionary companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

51.9% of Genus shares are owned by institutional investors. 0.7% of Genus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Genus has a net margin of 7.07% compared to ALLG.L's net margin of 0.00%. Genus' return on equity of 9.70% beat ALLG.L's return on equity.

Company Net Margins Return on Equity Return on Assets
Genus7.07% 9.70% 3.31%
ALLG.L N/A N/A N/A

Genus has higher revenue and earnings than ALLG.L.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genus£672M2.26£7.87M£71.0032.14
ALLG.LN/AN/AN/AN/AN/A

Genus presently has a consensus price target of GBX 3,216.67, suggesting a potential upside of 40.96%. Given Genus' stronger consensus rating and higher probable upside, equities research analysts plainly believe Genus is more favorable than ALLG.L.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
ALLG.L
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Genus' average media sentiment score of 0.00 equaled ALLG.L'saverage media sentiment score.

Company Overall Sentiment
Genus Neutral
ALLG.L Neutral

Summary

Genus beats ALLG.L on 9 of the 9 factors compared between the two stocks.

How does Genus compare to CVS Group?

Genus (LON:GNS) and CVS Group (LON:CVSG) are both small-cap consumer discretionary companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.4%. CVS Group pays an annual dividend of GBX 8.50 per share and has a dividend yield of 0.7%. Genus pays out 45.1% of its earnings in the form of a dividend. CVS Group pays out 12.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Genus currently has a consensus price target of GBX 3,216.67, indicating a potential upside of 40.96%. CVS Group has a consensus price target of GBX 1,720, indicating a potential upside of 32.72%. Given Genus' stronger consensus rating and higher possible upside, research analysts clearly believe Genus is more favorable than CVS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
CVS Group
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

In the previous week, Genus' average media sentiment score of 0.00 equaled CVS Group'saverage media sentiment score.

Company Overall Sentiment
Genus Neutral
CVS Group Neutral

Genus has a beta of 0.896, indicating that its stock price is 10% less volatile than the broader market. Comparatively, CVS Group has a beta of 1.066, indicating that its stock price is 7% more volatile than the broader market.

CVS Group has higher revenue and earnings than Genus. CVS Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genus£672M2.26£7.87M£71.0032.14
CVS Group£692.80M1.28£20.68M£68.9018.81

Genus has a net margin of 7.07% compared to CVS Group's net margin of 2.31%. Genus' return on equity of 9.70% beat CVS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Genus7.07% 9.70% 3.31%
CVS Group 2.31%5.35%5.03%

51.9% of Genus shares are owned by institutional investors. Comparatively, 48.5% of CVS Group shares are owned by institutional investors. 0.7% of Genus shares are owned by insiders. Comparatively, 1.4% of CVS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Genus beats CVS Group on 9 of the 16 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNS vs. The Competition

MetricGenusDiversified Consumer Services IndustryConsumer Discretionary SectorLON Exchange
Market Cap£1.53B£4.36B£13.21B£2.54B
Dividend Yield1.43%2.80%56.57%6.17%
P/E Ratio32.1410.3446.96367.57
Price / Sales2.2637.3088.6683,481.74
Price / Cash50.5614.4429.1327.89
Price / Book2.763.193.937.19
Net Income£7.87M£242.43M£445.72M£5.89B
7 Day Performance1.15%-0.18%-0.26%0.30%
1 Month Performance6.90%0.07%2.74%3.31%
1 Year Performance-15.17%-4.79%-1.57%22.13%

Genus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNS
Genus
3.1964 of 5 stars
GBX 2,282
-0.7%
GBX 3,216.67
+41.0%
-15.2%£1.53B£672M32.14480
IGG
IG Group
2.3348 of 5 stars
GBX 1,339
-3.3%
GBX 1,338
-0.1%
+15.7%£4.42B£949.10M12.742,754
SMWH
WH Smith
N/AGBX 420.40
+0.1%
GBX 570
+35.6%
-41.3%£632.70M£1.59BN/A14,935
CPG
Compass Group
3.336 of 5 stars
GBX 31.34
-0.3%
GBX 2,932.50
+9,257.1%
-98.8%£532.88M£48.49B0.26550,000
ALLG
ALLG.L
N/AGBX 7.97
-0.1%
N/AN/A£0.00N/AN/A140

Related Companies and Tools


This page (LON:GNS) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners